Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 43

Results For "ALS"

7974 News Found

USFDA conducts inspection at Alembic Pharmaceuticals' Panelav oncology formulation facility
Drug Approval | March 09, 2024

USFDA conducts inspection at Alembic Pharmaceuticals' Panelav oncology formulation facility

The company will provide comprehensive response to USFDA for the observations


Healthcare Sector Skill Council organises convocation ceremony of Ayush skilled professionals
News | March 06, 2024

Healthcare Sector Skill Council organises convocation ceremony of Ayush skilled professionals

The Convocation ceremony was organized for students skilled and certified in Ayush


KIMS Hospitals to acquire land on 99-year lease to set up new hospital at Thane
Healthcare | March 05, 2024

KIMS Hospitals to acquire land on 99-year lease to set up new hospital at Thane

The proposed hospital will have a bed capacity of 300 beds and the investment in the project is expected to be around Rs. 500 crore


Briefs: SMS Pharmaceuticals and Vimta Labs
News | March 03, 2024

Briefs: SMS Pharmaceuticals and Vimta Labs

EDQM conducts GMP inspection of SMS Pharmaceuticals’ API facility


Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India
News | February 24, 2024

Briefs: Suven Pharmaceuticals, Remedium Lifecare and Kilitch Drugs India

Suven Pharmaceuticals’ API and forumulations facilities complete USFDA inspection successfully


Briefs: IOL Chemicals and Pharmaceuticals and Auro Peptides
News | February 20, 2024

Briefs: IOL Chemicals and Pharmaceuticals and Auro Peptides

IOL Chemicals and Pharmaceuticals’ product approved by CDE of NMPA, China


Mankind Pharma tie-ups with Lepra Society to establish CDCC Centres to screen 80,000 individuals
Healthcare | February 15, 2024

Mankind Pharma tie-ups with Lepra Society to establish CDCC Centres to screen 80,000 individuals

The CDCCs are strategically positioned in regions identified as high-impact areas


MIRA Pharmaceuticals announces collaboration with Pharmaseed
News | February 08, 2024

MIRA Pharmaceuticals announces collaboration with Pharmaseed

Studies will Investigate Antidepressant Properties of Ketamir to Position for Initial IND Application in 2024